After adjusting for sex, age, TNM stage, and lymphovascular invasion, CD44(+) patients had a significantly higher risk of gastric cancer-related death compared with CD44(−) patients (odds ratio (OR) = 1.57; 95% CI: 1.05–2.36; P = 0.029). Here, CD44 is linked to gastric cancer.